Conclusion. Data suggest that interventions targeted at reducing longterm dependence on PEG tubes take into account not only treatmentrelated factors, but also the important role that social support plays.
INTRODUCTION
Advancements in treatment for head and neck cancer over the past decade have resulted in maintenance of organ anatomy, increased tumor control, and increased survival, but not without severe oral complications. [1] [2] [3] [4] [5] [6] [7] [8] [9] In fact, dysphagia is one of the most serious and persistent complications associated with all treatments for patients with head and neck cancer, particularly radiation therapy. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Percutaneous endoscopic gastrostomy (PEG) tubes are routinely placed in patients with head and neck cancer, both before and after onset of treatment, in order to provide temporary nutritional support until adequate oral intake is possible after completion of treatment. 23, 24 Unfortunately, the resumption of oral intake does not occur in all patients, and dependence on feeding tubes has been defined as one of the most debilitating late toxicities associated with treatment for head and neck cancers. 25 Research, including our own work, has just begun to examine patient, tumor, and treatment factors associated with long-term dependence on PEG tubes in head and neck cancer survivors. 23, [26] [27] [28] [29] [30] Patient characteristics associated with long-term dependence on PEG tubes include older age, preoperative weight loss, and heavy alcohol use. Tumor characteristics include tumor site (larynx/ hypopharynx primary site and pharyngeal tumors) and advanced stage disease. Treatment-related factors associated with long-term dependence on PEG tubes include neck dissection after chemoradiation therapy and the addition of chemotherapy to definitive radiation therapy. To our knowledge, no study has investigated the important role that social support may play in long-term dependence on PEG tubes in head and neck cancer survivors. Recent work has demonstrated that men without partners who participated in Radiation Therapy Oncology Group head and neck cancer trials experienced worse overall survival compared with men who had partners; and this is true for all patients diagnosed with any type of cancer. 31, 32 Other work has similarly found that patients with head and neck cancer with low ratings of perceived posttreatment social support experienced poorer health-related quality of life across several domains. 9 These findings are not surprising as a large body of research over an extended period of time provide strong and compelling evidence linking social support and networks with positive health outcomes. 33, 34 Our own recent work has described the important role that social support, and particularly spousal caregivers, play in providing nutritional support to older adults with cancer, including patients with head and neck cancer. 35, 36 Head and neck cancer survivors without partners may lack necessary social support that might facilitate removal of PEG tubes.
Thus, the purpose of this study was to evaluate whether head and neck cancer survivors who did not have partners were more likely than survivors with partners to experience long-term dependence on PEG tubes. We hypothesized that survivors without partners would be more likely to be dependent on PEG tubes 12 months after treatment compared with survivors with partners.
MATERIALS AND METHODS

Participants
One hundred fifty-four patients who had a PEG tube placed before treatment for carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx at the University of Alabama at Birmingham and who were seen in the Otolaryngology Clinic between 2002 and 2004 were included in the study. Additionally, patients had to have survived and to have follow-up visits of at least 12 months posttreatment in order to determine whether the PEG tube was still in place or less if the PEG tube was removed earlier. Exclusion criteria included patients receiving a PEG tube for carcinoma of the nasopharynx, maxillary sinus or skull base, lymphoma, neurological defects, ventilatory dependence, or palliative treatments.
Design
The study used a retrospective cohort design. Medical records were selected for review based upon the criteria described above. The study protocol was reviewed and approved by the University of Alabama at Birmingham Institutional Review Board.
Measurement
The dependent measure was long-term dependence on PEG tubes, defined as PEG tube placement 12 months after treatment. The primary independent variable was partner status defined as either married or living with someone as a partner (yes or no). Independent variables that were controlled for in our analyses, because it was thought that they might affect long-term dependence on PEG tubes, included patient characteristics, tumor characteristics, and treatment characteristics.
Patient characteristics included age, sex, race, and insurance status (yes or no).
Tumor characteristics included cancer site, TMN stage, and overall stage.
Treatment characteristics included: surgery (including the subsets of tracheotomy, free-flap reconstruction, and salvage surgery), radiation, chemotherapy, or a combination of any of the 3.
Statistical analysis
Descriptive statistics were used to characterize the sample. Chi-square and t test statistics were used to evaluate bivariate associations between PEG tube dependence and the independent variables. A multivariate binary logistic regression was performed to analyze the effect of partner status, while controlling for the other independent variables that were statistically significant in the bivariate analyses, on long-term PEG tube dependence. A p value of .05 was considered statistically significant.
RESULTS
Patient characteristics
One hundred fifty-four patients were identified who met the study criteria. Of those 154 patients, 16 patients had 17 additional PEG procedures performed from 2002 to 2007. Twelve patients had 13 secondary PEG tubes placed for recurrent disease. Two patients had additional feeding tubes placed for chronic dysphagia. One patient had a second PEG tube placed for aspiration pneumonia, and 1 patient had an additional feeding tube placed for ventilator dependence. Table 1 presents baseline characteristics of patients broken down according to whether or not a PEG tube was in place at 12 months after treatment. The patients included 116 men and 38 women ranging in age from 31 to 85 years, with a mean age of 59.6 years. The majority of patients were white (83.1%) and insured (84.4%). Patients who were African American were more likely to have a PEG tube in place at 12 months. Thirtythree patients (21.4%) had a history of treatment for head and neck cancer. The period of observation that commenced 12 months after treatment ranged from 1 month to 58 months.
Partner status
Thirty-seven percent of patients did not have a partner. Those without partners were more likely to have PEG tubes in place at 12 months.
Tumor characteristics
The most common head and neck sites were the oropharynx (37.0%), oral cavity (35.1%), and larynx (23.4%). Advanced stage was the most common presentation with 36.4% of patients presenting with a T4 lesion, 34.4% presenting with a T3 lesion, and 22.7% presenting with a T2 lesion. Nearly all patients presented with stage III or IV disease (89.5%; Table 1 ).
Treatment characteristics
Patients in the study were treated either with primary radiation (5%), combined chemoradiation (28%), primary surgical extirpation (21%), surgery with postoperative radiation (27%), or salvage surgery for recurrent disease after primary radiation (15%).
Sixty-seven percent of the patients underwent surgery. Free-flap reconstruction was performed in 53.2% of the patients and 15% of patients underwent salvage surgery. Thirteen of the patients (8.4%) had a tracheotomy tube for longer than 30 days (Table 1) .
Seventy-nine percent of patients received radiation treatment, and receipt of radiation therapy was significantly associated with PEG tube dependence at 12 months. Primary radiation was performed in 48.7% of the patients and postoperative radiation was given to 31.2% of the patients. Chemotherapy was given to 37.7% of the patients (Table 1) .
Long-term percutaneous endoscopic gastrostomy tube dependence
The majority of patients (74.7%) had their PEG tube removed before 12 months. Correspondingly, 25.3% had a PEG tube at 12 months; and 16.2% had a PEG tube at 24 months. Eighty percent of patients who had a PEG tube at 12 months still had a PEG tube in place at 24 months.
Logistic regression
The results of the logistic regression model are presented in Table 2 . Based upon bivariate analyses, 4 covariates were included in our logistic regression model: partner status (with vs without a partner), race (white vs African American), radiation therapy (yes vs no), and tracheotomy tube dependence >30 days (yes vs no). Findings reveal that the odds of long-term PEG tube dependence were greater for those who did not have partners compared with those who had partners (odds ratio [OR], 3.33; p ¼ .004), for patients who received radiation therapy (OR, 6.21; p ¼ .018), and for those who had a tracheotomy in place for longer than 30 days (OR, 4.328; p ¼ .035). Race was not statistically significant.
DISCUSSION
Long-term nutritional support using PEG tubes may be beneficial to patients undergoing treatment for head and neck cancer, especially for those with advanced-stage cancer who will undergo aggressive radiation therapy. Use of PEG tubes is not without risk, though, including likelihood of long-term dependence of use. Debate exists regarding the timing of the placement of a PEG tube in these patients. While this controversy exists, the focus of this study was to identify those patients who had a PEG tube placed and whether presence of a partner influenced long-term dependence.
There is no consensus on the definition of long-term PEG tube use. Schweinfurth et al 28 reported long-term use to be more than 6 weeks and less than 1 year after treatment. Gardine et al 29 defined long-term enteral support to be more than 30 days. That study included patients with nasogastric, esophagostomy, and gastrostomy tubes. The present report uses a broader definition for long-term use. Because treatment for head and neck cancer may last up to 3 months in duration, and recovery may also take several months, tube feeding after 12 months of completion of treatment was determined to be long-term. In our study, we found that approximately one fifth of patients who underwent PEG tube placement to support nutritional feeding during treatment for head and neck cancer still had the tube in place within the first year; and patients with PEG tubes at 1 year were not likely to have the tube removed within a year later.
Patients undergoing treatment for head and neck cancer are likely to experience significant problems with nutritional intake. 4, 5 Anticancer therapies designed to treat patients with head and neck cancer contribute significantly to nutritional problems. This is related to both the decreased nutrient intake associated with the side effects of the treatments and to the increased nutrients that are required because of the increased metabolic needs and the physical stressors associated with the duration and intensity of the treatments. Acute and late toxicity that occurs during and after radiation treatment, including mucositis, infection, salivary gland dysfunction, taste dysfunction, pain, xerostomia, rampant dental carries, soft tissue necrosis, and osteonecrosis, is the result of the high volume and doses of the radiation treatment. 37 Patients who undergo surgery may additionally experience functional and anatomical impairments that interfere with chewing and swallowing. Finally, in addition to experiencing ulcerative oral mucositis and bacterial and viral infections, patients who undergo chemotherapy are likely to experience nausea and vomiting.
Two treatment-related factors were significantly related to long-term PEG tube dependence in this study: receipt of radiation as part of treatment (OR, 6.21; p ¼ .018) and presence of a tracheotomy tube for longer than 30 days (OR, 4.328; p ¼ .035). In contrast, surgery (OR, 1.72; p ¼ .431) or the addition of chemotherapy (OR, 1.27; p ¼ .729) were not found to be significantly associated with dependence. These findings are unexpected as it is commonly believed that the effects of surgery on the head and neck may significantly contribute to severe swallowing disability. [39] [40] [41] However, in 2 other studies, it was found that free-flap reconstruction may provide reasonable swallowing function in patients undergoing resection of head and neck cancer. 42, 43 This suggests a plausible explanation for the findings of this study.
The 1 surgical factor that did demonstrate an association with long-term PEG tube use was the presence of a tracheotomy for more than 30 days. Leder et al 41 reported that a tracheotomy tube did not predispose a patient with head and neck cancer to aspiration or that decannulation led to improved swallowing function. Instead, they concluded that a tracheotomy tube better indicated other comorbidities that predispose a patient to dysphagia. Although this present study identified patients with tracheotomies to be at risk for long-term PEG use, it did not identify the cause.
Patient characteristics directly influence nutritional status in patients with head and neck cancer as well. Risk factors associated with head and neck cancer, including low socioeconomic status, male sex (especially if living alone), older age, and the heavy use of alcohol and tobacco, are also the same risk factors which may affect dietary intake and quality of diet. 38 Whereas most studies have focused on tumor and treatment-related factors that lead to malnutrition, Locher et al 35, 36 identified social factors that contribute to nutritional difficulties in adults with cancer and found that matters related to nutrition activities were a source of significant distress for patients and caregivers. Additionally, patients who are older, who have significant preoperative weight loss, and those with a history of heavy alcohol use are noted to be at risk for long-term enteral support. [37] [38] [39] This study has identified another important patientrelated factor associated with long-term PEG tube dependence-namely being without a partner. Single patients were found to be 3.33 times more likely to use their PEG tube at 12 months than patients with partners (p ¼ .004). Recent work has demonstrated that men without partners who participated in Radiation Therapy Oncology Group head and neck trials experienced worse overall survival compared with men who had partners. 31 Our own recent work has described the important role that social support, and particularly spousal caregivers, play in providing nutritional support to older adults with cancer, including patients with head and neck cancer. 35, 36 Head and neck cancer survivors without partners may lack necessary social support that might facilitate removal of PEG tubes. Work by Karnell et al 9 support this observation; they suggest that clinical interventions focused on social support have the potential to improve survivorship of patients with head and neck cancer across multiple domains, including eating. The mechanisms by which such social support may operate is varied. Survivors may be encouraged to engage in healthy behaviors, including consuming food orally. Additionally, eating is a social activity that requires others' presence for its full enjoyment; without partners, patients may be less motivated to have PEG tubes removed simply to eat alone. Moreover, food and eating activities require much work; and reliance on a PEG tube might require less effort than engaging in all of the activities required to feed oneself orally. Finally, receipt of social support, especially by a partner, may directly or indirectly enhance one's personal competence and enable one to access relevant nutritional supportive resources or services. This may be especially important for head and neck cancer survivors who experience dysphagia and might need supportive services by speech pathologists and dieticians.
It may also be the case that partner status is a proxy for late stage of presentation of cancer, such that patients without partners are more likely to present with advanced illness, which may be associated with long-term PEG tube use. While our findings on tumor characteristics were not statistically significant, the observed associations were in the expected directions. Also, tumor stage seemed important such that patients with T4 tumors were 3.67 times more likely to have a feeding tube at 1 year (p ¼ .097). In post-hoc analysis, we examined whether tumor stage and partner status were associated with one another. There seemed to be a trend with patients without partners presenting with later-stage disease, but this finding was not statistically significant. Lack of association in both of these cases may be attributable to small sample size and future investigation is clearly warranted.
Other tumor characteristics, namely tumor site, have also been implicated in long-term PEG tube use. The anatomical location of the tumor restricts swallowing leading to reduced caloric intake. Again, Schweinfurth et al 28 noted that tumors involving the base of the tongue and Gardine et al 29 reported that advanced-stage tumors predict the need for long-term PEG feeding. It was noted that tumor site approached significance with patients having tumors of the oropharynx and hypopharynx to be 2.5 times more likely to rely on PEG tube feeding at 1 year (p ¼ .112).
It is important to note that race was significantly associated with long-term PEG tube use in our bivariate analysis, but not in the multivariate logistic regression model. We performed several sensitivity analyses to evaluate whether the effect of race was masked by marital status-that is, were African Americans less likely to have a partner. This was not the case. Race may be an independent predictor of long-term dependence of PEG tubes, but our sample size was not sufficiently large enough to detect a statistically significant relationship. This disparate finding warrants further investigation.
Our study relied upon 1 single measure of social support (ie, the presence or absence of a partner). There are certainly other sources of social support that are important as well. Additionally, we do not know precisely how social support operates for patients with head and neck cancer. Future work that includes: (1) a more comprehensive assessment of sources of social support for patients with head and neck cancer and survivors and (2) elucidation of the mechanisms by which social support works to improve quality of life, especially as it relates to eating behavior, is clearly warranted.
Our study was limited by its relatively small sample size, utilization of a single site, lack of inclusion of some potentially relevant data (eg, comorbidity), and lack of a randomized controlled design. Nonetheless, findings from our study contribute to the growing evidence base regarding how to provide better nutritional support for patients undergoing treatment for head and neck cancer. Further health services research using large databases like the Surveillance, Epidemiology, and End Results-Medicare database and randomized clinical trials are necessary to determine more definitively the benefits and risks of PEG tube placement in patients with head and neck cancer and to evaluate the role of social support in supportive care interventions.
